Ketanserin (Tartrate) Overview Categories 12 Cardiovascular drugs12.8 Other cardiovascular preparations Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Methyldopa Manufacturers of Methyldopa Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Methyldopa's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 40 mg40 (40)As recommended.0.142 mg/kg0.14 (0.142)As recommended.IMEvery 15-30 minutes, As Required0.042 to 0.428 mg/kg.min0.23 (0.235)As recommended.IV InfAs Required20 mg20 (20)12 hourlyPOFor 2-4 weeks Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Methyldopa is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Methyldopa is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Methyldopa Back to top Manufacturers of Ketanserin (Tartrate) in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Ketanserin (Tartrate) Overview Categories 12 Cardiovascular drugs12.8 Other cardiovascular preparations Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Methyldopa Manufacturers of Methyldopa Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Methyldopa's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 40 mg40 (40)As recommended.0.142 mg/kg0.14 (0.142)As recommended.IMEvery 15-30 minutes, As Required0.042 to 0.428 mg/kg.min0.23 (0.235)As recommended.IV InfAs Required20 mg20 (20)12 hourlyPOFor 2-4 weeks Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Methyldopa is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Methyldopa is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Methyldopa Back to top Manufacturers of Ketanserin (Tartrate) in Pakistan Back to top Previous Drug Generic - Next Drug Generic